Reaction
Medical Procedure reporting signals
As of the last recalculation, Medical Procedure appears in 1,617 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 70.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 46 | 70.7 | 71.1 |
| Ibrutinib | 288 | 55.6 | 55.8 |
| Risankizumab-Rzaa | 129 | 22.0 | 22.0 |
| Riociguat | 51 | 20.8 | 20.8 |
| Avapritinib | 19 | 20.4 | 20.5 |
| Upadacitinib | 119 | 20.2 | 20.2 |
| Venetoclax | 50 | 10.8 | 10.8 |
| Tolvaptan | 12 | 10.7 | 10.7 |
| Amikacin | 14 | 10.6 | 10.7 |
| Pancrelipase | 31 | 10.5 | 10.5 |
| Ivacaftor | 6 | 9.8 | 9.8 |
| Macitentan | 47 | 9.0 | 9.0 |
| Sorafenib | 13 | 8.1 | 8.1 |
| Regorafenib | 7 | 7.8 | 7.8 |
| Relugolix | 14 | 7.7 | 7.7 |
| Sodium Oxybate | 37 | 7.4 | 7.4 |
| Selexipag | 14 | 7.0 | 7.0 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 19 | 7.0 | 7.0 |
| Epoprostenol | 7 | 6.9 | 6.9 |
| Oral Semaglutide | 37 | 6.6 | 6.6 |
| Vibegron | 4 | 6.4 | 6.4 |
| Voxelotor | 10 | 5.8 | 5.8 |
| Carbidopa And Levodopa | 21 | 5.8 | 5.8 |
| Rimegepant Sulfate | 5 | 5.1 | 5.1 |
| Dofetilide | 4 | 4.9 | 4.9 |
| Apalutamide | 4 | 4.4 | 4.4 |
| Fremanezumab-Vfrm | 3 | 3.4 | 3.4 |
| Tapentadol Hydrochloride | 8 | 3.1 | 3.1 |
| Bimekizumab | 5 | 3.0 | 3.0 |
| Droxidopa | 5 | 3.0 | 3.0 |
| Esketamine Hydrochloride | 4 | 2.9 | 2.9 |
| Cinacalcet Hydrochloride | 9 | 2.5 | 2.5 |